Lactobacillus salivarius (LS-33)
Mechanism of Action +
### Biochemical Classification and Metabolism Lactobacillus salivarius is a species of Gram-positive, non-spore-forming, homofermentative bacteria. As a homofermentative organism, its primary metabolic pathway involves the conversion of carbohydrates (specifically hexoses) almost exclusively into lactic acid via the Embden-Meyerhof-Parnas (glycolysis) pathway. The enzyme lactate dehydrogenase catalyzes the final step, reducing pyruvate to lactate. This massive localized production of lactic acid is a critical mechanism of action, as it rapidly lowers the microenvironmental pH in the colon, vagina, and oral cavity. This acidic shift creates an inhospitable environment for acid-sensitive pathogenic bacteria and opportunistic fungi, such as Candida albicans.
### Bacteriocin Production and Antimicrobial Activity One of the most defining biochemical features of Lactobacillus salivarius strains, including LS-33, is their robust bacteriocinogenic capacity. Bacteriocins are ribosomally synthesized antimicrobial peptides that exhibit targeted bactericidal or bacteriostatic effects against closely related bacterial species and various pathogens. L. salivarius is known to produce specific class II bacteriocins (such as salivaricin). These amphiphilic peptides function by binding to specific receptors on the surface of target pathogenic cells. Upon binding, they insert themselves into the lipid bilayer of the pathogen's cell membrane, oligomerize, and form pores. This pore formation leads to a rapid efflux of intracellular ions (such as potassium and phosphate), dissipation of the proton motive force, depletion of intracellular ATP, and ultimately, cell death. This targeted 'antibiotic' production allows LS-33 to actively suppress invading pathogens while sparing the broader, beneficial commensal microbiome.
### Competitive Exclusion and Mucosal Adhesion The efficacy of LS-33 is heavily dependent on its ability to adhere to host epithelial cells and mucin. This adhesion is mediated by surface layer proteins (SLPs), lipoteichoic acids, and specific mucin-binding proteins expressed on the bacterial cell wall. By physically occupying binding sites on the intestinal, oral, and vaginal epithelia, LS-33 prevents the attachment and subsequent colonization of pathogenic enterobacteria (a process known as steric hindrance or competitive exclusion). Furthermore, LS-33 competes aggressively for essential nutrients within the mucosal microenvironment, effectively starving out slower-growing or less adapted pathogenic strains.
### Enhancement of Mucosal Barrier Integrity Beyond physical exclusion, LS-33 actively reinforces the structural integrity of the host's mucosal barrier. The intestinal epithelium relies on tight junction protein complexes (including ZO-1, occludin, and claudins) to prevent the paracellular translocation of luminal antigens and endotoxins (such as lipopolysaccharides) into the systemic circulation. L. salivarius metabolites, including short-chain fatty acids (SCFAs) generated through cross-feeding with other commensals, stimulate the upregulation and proper localization of these tight junction proteins. This anti-permeability effect is crucial in mitigating 'leaky gut' syndrome and reducing the low-grade systemic inflammation associated with endotoxemia.
### Immunomodulation and Cytokine Regulation Lactobacillus salivarius LS-33 interacts directly with the host immune system via the gut-associated lymphoid tissue (GALT). The bacterial cell wall components (peptidoglycan, lipoteichoic acid) act as microbe-associated molecular patterns (MAMPs) that are recognized by pattern recognition receptors (PRRs), specifically Toll-like receptors (TLR2 and TLR4), located on the surface of intestinal epithelial cells and underlying dendritic cells.
Upon TLR engagement, a signaling cascade is initiated, often involving the NF-κB and MAPK pathways. LS-33 has been shown to exert a regulatory effect on these pathways, promoting the maturation of dendritic cells toward a tolerogenic phenotype. This results in the induction of regulatory T cells (Tregs) and a shift in the cytokine profile. Specifically, LS-33 promotes the secretion of anti-inflammatory cytokines such as Interleukin-10 (IL-10) and Transforming Growth Factor-beta (TGF-β), while downregulating the production of pro-inflammatory cytokines like Tumor Necrosis Factor-alpha (TNF-α), IL-6, and IL-1β. This immunomodulatory capacity underpins the strain's anti-allergic properties and its ability to assist in the regulation of inflammatory digestive conditions.
### Pharmacokinetics and Survivability For a probiotic to be effective, it must survive the harsh conditions of the upper gastrointestinal tract. Lactobacillus salivarius LS-33 exhibits significant intrinsic resistance to gastric acid and bile salts. The strain utilizes specific stress-response mechanisms, including the upregulation of F0F1-ATPase to pump protons out of the cell and maintain intracellular pH homeostasis in the acidic stomach environment. Additionally, it produces bile salt hydrolase (BSH) enzymes, which deconjugate primary bile acids in the duodenum, rendering them less toxic to the bacterial cell and allowing LS-33 to successfully transit to and colonize the lower intestine and colon.
What is lactobacillus salivarius LS 33? +
Who should not take lactobacillus salivarius? +
Which lactobacillus salivarius is best? +
What infections does Lactobacillus salivarius help with? +
Does Lactobacillus salivarius interact with medications? +
What drugs should not be taken with probiotics? +
Does Lactobacillus interact with anything? +
What are the symptoms of too much Lactobacillus in the gut? +
How do I take Custom Probiotics LS-33 powder? +
Is LS-33 dairy-free? +
Can children take L. salivarius LS-33? +
Does LS-33 need to be refrigerated? +
How does L. salivarius help with Candida? +
What are bacteriocins? +
Can L. salivarius improve oral health? +
How long does it take for LS-33 to work? +
Are there any allergens in LS-33 powder? +
Why take probiotics on an empty stomach? +
Everything About Lactobacillus salivarius (LS-33) Article
## Introduction to Lactobacillus salivarius LS-33
Lactobacillus salivarius is one of the most versatile and aggressive beneficial bacterial strains found within the human microbiome. Naturally residing in the colon, small intestines, vagina, and oral cavity, this specific species plays a critical role in defending the body against pathogenic invaders. The specific strain, Lactobacillus salivarius LS-33 (often cataloged as CP-2010 in specialized formulations), represents a highly concentrated, therapeutic-grade variant designed to aggressively restore microbiome balance.
Unlike milder probiotic strains, L. salivarius is renowned for its ability to produce its own targeted antibiotics, known as bacteriocins. These compounds actively hunt and neutralize invading pathogenic bacteria, making LS-33 a powerful tool for individuals dealing with dysbiosis, Candida overgrowth, or chronic inflammatory digestive conditions.
## The Science of Strain LS-33: Mechanisms of Action
To understand why Lactobacillus salivarius LS-33 is so effective, we must look at its biochemical mechanisms. The strain operates through a multi-pronged approach to secure and optimize the mucosal environments of the body.
### 1. Bacteriocin Production The most remarkable feature of L. salivarius is its bacteriocinogenic nature. Bacteriocins are antimicrobial peptides synthesized by the probiotic that specifically target and destroy harmful bacteria. They do this by binding to the cell membranes of pathogens and forming pores, causing the pathogenic cells to leak their contents and die. This allows LS-33 to actively clear out 'bad' bacteria without harming the beneficial flora.
### 2. Lactic Acid Fermentation As a homofermentative bacterium, LS-33 converts carbohydrates almost entirely into lactic acid. This massive production of lactic acid rapidly lowers the pH of the surrounding environment (whether in the gut, vagina, or mouth). Pathogens and opportunistic fungi, such as *Candida albicans*, struggle to survive in highly acidic environments. By lowering the pH, LS-33 creates an inhospitable zone for these invaders.
### 3. Competitive Exclusion LS-33 is a highly adherent strain. It binds tightly to the epithelial cells and mucin lining the gastrointestinal and urogenital tracts. By physically occupying these binding sites, it prevents pathogens from attaching and establishing a foothold—a process known as competitive exclusion. Furthermore, it aggressively consumes available nutrients, effectively starving out competing harmful bacteria.
## Core Health Benefits and Clinical Applications
### Gastrointestinal Health and Mucosal Integrity A healthy gut lining is essential for preventing 'leaky gut' syndrome, where toxins and undigested food particles escape into the bloodstream, triggering systemic inflammation. L. salivarius LS-33 supports the maintenance of mucosal integrity by encouraging the production of tight junction proteins. It also assists in the regulation of inflammatory digestive conditions by modulating the local immune response, reducing pro-inflammatory cytokines, and promoting tissue healing.
### Anti-Candida and Antimicrobial Properties Fungal overgrowth, particularly *Candida albicans*, is a common consequence of antibiotic use, high-sugar diets, or stress. LS-33 is highly regarded for its anti-Candida properties. Through the combined action of lactic acid production (which lowers pH) and the secretion of bacteriocins, LS-33 creates an antagonistic environment that suppresses Candida proliferation and helps restore healthy fungal-bacterial balance.
### Oral Health and Dental Defense Interestingly, L. salivarius is one of the dominant beneficial species found in a healthy human mouth (hence the name *salivarius*). Supplementation with this strain has been linked to improved oral health. By colonizing the oral cavity, it competes with cariogenic (cavity-causing) bacteria like *Streptococcus mutans* and bacteria responsible for halitosis (bad breath) and gingivitis. This makes it a popular ingredient in specialized probiotic toothpastes and oral powders.
### Immune System Modulation and Allergy Relief Over 70% of the human immune system resides in the gut. LS-33 interacts directly with the gut-associated lymphoid tissue (GALT). It has been shown to possess anti-allergic activities by shifting the immune system's Th1/Th2 balance, potentially reducing the severity of allergic responses. Furthermore, manufacturer data suggests it has anti-carcinogenic and anti-mutagenic properties, likely stemming from its ability to bind and neutralize certain dietary toxins and its profound regulatory effect on systemic inflammation.
### The Gut-Brain Axis: Potential in Autism Emerging research into the gut-brain axis has highlighted the profound impact of the microbiome on neurological and behavioral health. Clinical observations and specialized manufacturer data note that high-potency L. salivarius strains can have a positive influence on autistic children. While the exact mechanisms are still being researched, it is believed that by reducing gut inflammation, healing intestinal permeability, and altering the production of neuroactive microbial metabolites, LS-33 can help alleviate some of the gastrointestinal distress frequently observed in this population.
## Dosing Strategies: How to Take LS-33
Achieving therapeutic results with Lactobacillus salivarius LS-33 requires a strategic dosing protocol, particularly when using high-potency powders that deliver 300 billion CFUs per gram.
**For Adults:** The recommended starting dose is 0.8 grams (approximately one adult scoop, yielding 224 billion CFUs). This should be taken first thing in the morning on an empty stomach, at least 30 minutes prior to eating. Dissolve the powder in a glass of de-chlorinated water.
Stay at this initial dosage for 3 to 5 days to allow the microbiome to adjust. If further therapeutic benefit is required, the dose can be increased to two scoops daily (one in the morning, one at bedtime). In severe cases of dysbiosis, the dosage can be titrated up to a maximum of four scoops per day.
**For Children:** Children should start with a much smaller dose: 0.1 grams (approximately one baby scoop, yielding 25 billion CFUs) dissolved in water on an empty stomach. This can be gradually increased to up to four baby scoops daily, split between morning and evening, depending on the child's age and the desired clinical outcome.
*Note: Every digestive system is unique. Gradual titration is essential to find the optimum dosage and minimize initial Herxheimer (die-off) reactions or mild bloating.*
## Storage, Stability, and Purity
Premium formulations of LS-33, such as those from Custom Probiotics, are rigorously tested for stability. While the powder is temperature stable for 2 to 3 weeks without refrigeration (making it suitable for travel), it is highly recommended to store the product in the refrigerator for long-term optimum potency.
Furthermore, high-quality LS-33 powders are hypoallergenic. They are formulated to be strictly dairy-free and contain no sugar, gluten, soy, casein, yeast, artificial colors, flavors, preservatives, FOS, or genetically modified organisms (GMOs). This makes the strain highly accessible for individuals with severe food sensitivities or compromised immune systems.
## Conclusion
Lactobacillus salivarius LS-33 is a powerhouse probiotic strain that offers aggressive defense against pathogens, robust support for mucosal integrity, and profound immune modulation. Whether utilized for targeted anti-Candida protocols, oral health optimization, or general gastrointestinal restoration, its unique ability to produce targeted bacteriocins sets it apart from standard probiotic supplements. By following a careful, titrated dosing protocol, users can harness the full therapeutic potential of this remarkable microbe.